Rebuttal of Allegations Against Chlorine Dioxide Solution (CDS) - Revision history

Andreas at 18:10, 17 June 2025

2025-06-17T18:10:22Z

← Older revision		Revision as of 18:10, 17 June 2025
Line 1:		Line 1:
			[[File:CDS on trial.jpg\|thumb]]
	Gerhard Jonschker		Gerhard Jonschker

Line 5:		Line 6:
	Scientific Director - Expert Strategy , Company: Merck Group , Total Duration: 17 years 11 months		Scientific Director - Expert Strategy , Company: Merck Group , Total Duration: 17 years 11 months

	Gerhard Jonschker is a senior nanotechnology expert with extensive experience in research and development strategy. Former Senior Manager Strategic Marketing and later Associate Director . Over his career, he has contributed as an inventor to more than 70 patent families, reflecting his innovative impact on material sciences and technology development. Currently, he serves as Scientific Director and Expert Strategy at Merck Electronics KGaA and is affiliated with the INM Leibnitz Institute for New Materials.		Dr. Gerhard Jonschker is a senior nanotechnology expert with extensive experience in research and development strategy. Former Senior Manager Strategic Marketing and later Associate Director .

	~~Dr. Gerhard~~ Jonschker’s critique of MMS/CDS contains significant chemical inaccuracies that an experienced chemist should not make. His one-sided presentation appears influenced by his position as a Director at Merck, suggesting a potential conflict of interest. Moreover, he overlooks important scientific findings and controlled chlorine dioxide applications. Each of his points will be addressed and corrected with evidence-based arguments below.		Jonschker’s critique of MMS/CDS contains significant chemical inaccuracies that an experienced chemist should not make. His one-sided presentation appears influenced by his position as a Director at Merck, suggesting a potential conflict of interest. Moreover, he overlooks important scientific findings and controlled chlorine dioxide applications. Each of his points will be addressed and corrected with evidence-based arguments below.

	The article represents a scientific discussion and is not directed as "ad hominem". Any scientific comment is wellcome.		''The article represents a scientific discussion and is not directed as "ad hominem" confrontation.''

			Any scientific comment is wellcome.

	== 1. MMS-1, CDS, and MMS-2 as Chlorine Bleach ==		== 1. MMS-1, CDS, and MMS-2 as Chlorine Bleach ==

Andreas: /* 23. ClO₂ in Wound Treatment */

2025-06-17T17:34:08Z

23. ClO₂ in Wound Treatment

← Older revision		Revision as of 17:34, 17 June 2025
Line 205:		Line 205:
	'''Claim''': ClO₂ is suitable for wound treatment, but MMS contains byproducts.		'''Claim''': ClO₂ is suitable for wound treatment, but MMS contains byproducts.

	'''Rebuttal''': CDS is very suitable for wound treatment , even nosocomial necrosis remission is possible (https://dioxipedia.com/index.php?title=Post_surgery_nosocomial_necrosis). The author’s failure to distinguish CDS from MMS indicates scientific ignorance or ~~deliberte~~ missinformation.		'''Rebuttal''': CDS is very suitable for wound treatment , even nosocomial necrosis remission is possible (https://dioxipedia.com/index.php?title=Post_surgery_nosocomial_necrosis). The author’s failure to distinguish CDS from MMS indicates scientific ignorance or deliberate missinformation.

	== 24. Dosing Chaos ==		== 24. Dosing Chaos ==

Andreas: /* 8. ClO₂ as a Lung Toxin */

2025-06-17T16:54:06Z

8. ClO₂ as a Lung Toxin

← Older revision		Revision as of 16:54, 17 June 2025
Line 3:		Line 3:
	https://www.amazon.de/gp/customer-reviews/R13I5MJI1HLDN6/ref=cm_cr_srp_d_rvw_ttl?ie=UTF8&ASIN=3981409876		https://www.amazon.de/gp/customer-reviews/R13I5MJI1HLDN6/ref=cm_cr_srp_d_rvw_ttl?ie=UTF8&ASIN=3981409876

	Scientific Director - Expert Strategy		Scientific Director - Expert Strategy , Company: Merck Group , Total Duration: 17 years 11 months

	~~Company: Merck Group Total Duration: 17 years 11 months~~		Gerhard Jonschker is a senior nanotechnology expert with extensive experience in research and development strategy. Former Senior Manager Strategic Marketing and later Associate Director . Over his career, he has contributed as an inventor to more than 70 patent families, reflecting his innovative impact on material sciences and technology development. Currently, he serves as Scientific Director and Expert Strategy at Merck Electronics KGaA and is affiliated with the INM Leibnitz Institute for New Materials.

	Gerhard Jonschker is a ~~seasoned~~ nanotechnology expert with extensive experience in research and development strategy. Former Senior Manager Strategic Marketing and later Associate Director . Over his career, he has contributed as an inventor to more than 70 patent families, reflecting his innovative impact on material sciences and technology development. Currently, he serves as Scientific Director and Expert Strategy at Merck Electronics KGaA and is affiliated with the INM Leibnitz Institute for New Materials.

	Dr. Gerhard Jonschker’s critique of MMS/CDS contains significant chemical inaccuracies that an experienced chemist should not make. His one-sided presentation appears influenced by his position as a Director at Merck, suggesting a potential conflict of interest. Moreover, he overlooks important scientific findings and controlled chlorine dioxide applications. Each of his points will be addressed and corrected with evidence-based arguments below.		Dr. Gerhard Jonschker’s critique of MMS/CDS contains significant chemical inaccuracies that an experienced chemist should not make. His one-sided presentation appears influenced by his position as a Director at Merck, suggesting a potential conflict of interest. Moreover, he overlooks important scientific findings and controlled chlorine dioxide applications. Each of his points will be addressed and corrected with evidence-based arguments below.
Line 32:		Line 30:

	'''Rebuttal''': Chemical analysis shows less than 7.7% Cl₂/ClO₃⁻ in MMS (Noszticzius et al., 2013, doi:10.1371/journal.pone.0079157). CDS is electrolytically 99.9% pure. The “30%” claim is chemically implausible. As a chemist, the author should be fully aware of these chemical facts. Such a significant discrepancy strongly suggests intentional misinformation rather than a mere misunderstanding of the chemistry involved. Misrepresenting chemical composition in this way undermines scientific accuracy and misleads the public.		'''Rebuttal''': Chemical analysis shows less than 7.7% Cl₂/ClO₃⁻ in MMS (Noszticzius et al., 2013, doi:10.1371/journal.pone.0079157). CDS is electrolytically 99.9% pure. The “30%” claim is chemically implausible. As a chemist, the author should be fully aware of these chemical facts. Such a significant discrepancy strongly suggests intentional misinformation rather than a mere misunderstanding of the chemistry involved. Misrepresenting chemical composition in this way undermines scientific accuracy and misleads the public.

			'''Calculation''':

			* '''Molar Mass''': NaClO₂ (90.44 g/mol), ClO₂ (67.45 g/mol), Cl₂ (70.90 g/mol), ClO₃⁻ (83.45 g/mol).
			* '''MMS Solution''': 28% NaClO₂ (280 g/L). At 80% yield (Noszticzius et al., 2013, ), 215 g/L ClO₂ is produced.
			* '''Byproducts''': Studies indicate <5% Cl₂/ClO₃⁻
			** Cl₂: 5% of 215 g/L = 10.75 g/L.
			** ClO₃⁻: 10.75 g/L.
			** Total: (10.75 + 10.75) / 280 ≈ 7.7%.
			** The claim of “30% chlorine and chlorate” is chemically implausible, as byproducts constitute <10%. CDS, produced electrolytically, is 99.9% pure

	== 5. Toxicity and Lack of Efficacy ==		== 5. Toxicity and Lack of Efficacy ==
Line 58:		Line 66:

	== 8. ClO₂ as a Lung Toxin ==		== 8. ClO₂ as a Lung Toxin ==
	'''Claim''': Gaseous ClO₂ causes pulmonary edema. '''Rebuttal''': The claim that gaseous chlorine dioxide (ClO₂) causes pulmonary edema, while accurate in the context of direct inhalation exposure, does not apply to the clinical and therapeutic use of Chlorine Dioxide Solution (CDS). CDS is never administered as a gas; instead, it is given orally, rectally, dermatologically, or intravenously, which fundamentally changes its pharmacodynamics and safety profile.		'''Claim''': Gaseous ClO₂ causes pulmonary edema.

			'''Rebuttal''': The claim that gaseous chlorine dioxide (ClO₂) causes pulmonary edema, while accurate in the context of direct inhalation exposure, does not apply to the clinical and therapeutic use of Chlorine Dioxide Solution (CDS). CDS is never administered as a gas; instead, it is given orally, rectally, dermatologically, or intravenously, which fundamentally changes its pharmacodynamics and safety profile.

	Administration Routes and Safety:		Administration Routes and Safety:

Andreas: /* the 1. MMS-1, CDS, and MMS-2 as Chlorine Bleach */

2025-06-17T16:48:32Z

the 1. MMS-1, CDS, and MMS-2 as Chlorine Bleach

← Older revision		Revision as of 16:48, 17 June 2025
Line 11:		Line 11:
	Dr. Gerhard Jonschker’s critique of MMS/CDS contains significant chemical inaccuracies that an experienced chemist should not make. His one-sided presentation appears influenced by his position as a Director at Merck, suggesting a potential conflict of interest. Moreover, he overlooks important scientific findings and controlled chlorine dioxide applications. Each of his points will be addressed and corrected with evidence-based arguments below.		Dr. Gerhard Jonschker’s critique of MMS/CDS contains significant chemical inaccuracies that an experienced chemist should not make. His one-sided presentation appears influenced by his position as a Director at Merck, suggesting a potential conflict of interest. Moreover, he overlooks important scientific findings and controlled chlorine dioxide applications. Each of his points will be addressed and corrected with evidence-based arguments below.

	The article represents a scientific discussion and is not directed as "ad hominem". Any scientific comment is ~~wellcom~~.		The article represents a scientific discussion and is not directed as "ad hominem". Any scientific comment is wellcome.

	== ~~the~~ 1. MMS-1, CDS, and MMS-2 as Chlorine Bleach ==		== 1. MMS-1, CDS, and MMS-2 as Chlorine Bleach ==
	'''Claim''': MMS-1 and CDS are chlorine dioxide (ClO₂), a paper bleach; MMS-2 is calcium/sodium hypochlorite, a sanitary cleaner.		'''Claim''': MMS-1 and CDS are chlorine dioxide (ClO₂), a paper bleach; MMS-2 is calcium/sodium hypochlorite, a sanitary cleaner.

Andreas: /* 13. Herxheimer Reaction */

2025-06-17T16:47:29Z

13. Herxheimer Reaction

Show changes

Andreas: /* 12. Healing Reports Are Placebo */

2025-06-17T16:13:49Z

12. Healing Reports Are Placebo

@@ Line 92: / Line 92: @@
 == 12. Healing Reports Are Placebo ==
-'''Claim''': CDS healings are placebo effects. '''Rebuttal''': Animal studies (e.g., Dioxipedia case reports) show effects not attributable to placebo, as animals are not susceptible to placebo responses. Aparicio-Alonso et al. (2024, doi:10.56294/saludcyt20241162) report statistically significant recovery rates (99.3%).
+'''Claim''': CDS healings are placebo effects.
 == 13. Herxheimer Reaction ==

Andreas: /* 10. Jim Humble and Scientology */

2025-06-17T16:11:36Z

10. Jim Humble and Scientology

← Older revision		Revision as of 16:11, 17 June 2025
Line 80:		Line 80:

	== 10. Jim Humble and Scientology ==		== 10. Jim Humble and Scientology ==
	'''Claim''': Humble was a Scientologist and founded an MMS church. '''Rebuttal''': This ad hominem claim is unscientific and suggests deliberate manipulation by the author. CDS efficacy (Aparicio-Alonso et al., 2024) is independent of Humble’s background.		'''Claim''': Humble was a Scientologist and founded an MMS church.

			'''Rebuttal''': This ad hominem claim is unscientific and suggests deliberate manipulation by the author. CDS efficacy (Aparicio-Alonso et al., 2024) is independent of Humble’s background and irrelevant.

	== 11. No Proven Therapeutic Effect ==		== 11. No Proven Therapeutic Effect ==
	'''Claim''': No studies confirm CDS efficacy. '''Rebuttal''': Studies listed at ~~<nowiki>~~https://dioxipedia.com/index.php?title=CDS_Research_Studies~~</nowiki>~~ confirm efficacy:		'''Claim''': No studies confirm CDS efficacy.

			'''Rebuttal''': 128 Studies listed at https://dioxipedia.com/index.php?title=CDS_Research_Studies confirm efficacy:

	* ~~Aparicio-Alonso et al. (2024, doi:10.56294/saludcyt20241162): COVID-19.~~		*
	* Noszticzius et al. (2013, doi:10.1371/journal.pone.0079157): MRSA.
	* Fernández et al. (2024, doi:10.56294/saludcyt2024699): Cancer.
	* Insuasty et al. (2022, doi:10.3390/jcm11051404): Antibacterial.
	* Ma et al. (2017, doi:10.1016/j.jes.2017.03.017): Safety.
	* Morales et al. (2023, doi:10.3390/microorganisms11092231): Antiviral. Case reports document success in infections and cancer.

	== 12. Healing Reports Are Placebo ==		== 12. Healing Reports Are Placebo ==

Andreas at 16:09, 17 June 2025

2025-06-17T16:09:29Z

Show changes

Andreas: Created page with "Gerhard Jonschker https://www.amazon.de/gp/customer-reviews/R13I5MJI1HLDN6/ref=cm_cr_srp_d_rvw_ttl?ie=UTF8&ASIN=3981409876 Scientific Director - Expert Strategy Company: Merck Group Total Duration: 17 years 11 months Gerhard Jonschker is a seasoned nanotechnology expert with extensive experience in research and development strategy. Former Senior Manager Strategic Marketing and later Associate Director . Over his career, he has contributed as an inventor to more tha..."

2025-06-17T15:02:30Z

Created page with "Gerhard Jonschker https://www.amazon.de/gp/customer-reviews/R13I5MJI1HLDN6/ref=cm_cr_srp_d_rvw_ttl?ie=UTF8&ASIN=3981409876 Scientific Director - Expert Strategy Company: Merck Group Total Duration: 17 years 11 months Gerhard Jonschker is a seasoned nanotechnology expert with extensive experience in research and development strategy. Former Senior Manager Strategic Marketing and later Associate Director . Over his career, he has contributed as an inventor to more tha..."

New page

Gerhard Jonschker

https://www.amazon.de/gp/customer-reviews/R13I5MJI1HLDN6/ref=cm_cr_srp_d_rvw_ttl?ie=UTF8&ASIN=3981409876

Scientific Director - Expert Strategy

Company: Merck Group Total Duration: 17 years 11 months

Gerhard Jonschker is a seasoned nanotechnology expert with extensive experience in research and development strategy. Former Senior Manager Strategic Marketing and later Associate Director . Over his career, he has contributed as an inventor to more than 70 patent families, reflecting his innovative impact on material sciences and technology development. Currently, he serves as Scientific Director and Expert Strategy at Merck Electronics KGaA and is affiliated with the INM Leibnitz Institute for New Materials.

Dr. Gerhard Jonschker’s critique of MMS/CDS contains significant chemical inaccuracies that an experienced chemist should not make. His one-sided presentation appears influenced by his position as a Director at Merck, suggesting a potential conflict of interest. Moreover, he overlooks important scientific findings and controlled chlorine dioxide applications. Each of his points will be addressed and corrected with evidence-based arguments below.

The article represents a scientific discussion

== the 1. MMS-1, CDS, and MMS-2 as Chlorine Bleach ==
'''Claim''': MMS-1 and CDS are chlorine dioxide (ClO₂), a paper bleach; MMS-2 is calcium/sodium hypochlorite, a sanitary cleaner. '''Rebuttal''': Andreas Kalcker explicitly rejects MMS-2 (calcium hypochlorite), as it is unrelated to CDS, which is pure ClO₂ (Kalcker, 2023,). ClO₂ is a disinfectant, safe at 0.3–3 mg/L (Lubbers et al., 1982, doi:10.1289/ehp.824663). Aparicio-Alonso et al. (2024, doi:10.56294/saludcyt20241162) demonstrate safety at 1.41 mg/kg in 1,136 COVID-19 patients (6.78% mild side effects). MMS-2 releases hypochlorous acid (HOCl), not sodium hypochlorite (Young, 2016, doi:10.15406/ijvv.2016.02.00052). The “chlorine bleach” label is misleading.

== 2. Illegality and Penalties for MMS ==
'''Claim''': MMS is illegal, classified as quackery, and its sale incurs penalties. '''Rebuttal''': CDS is legal in Bolivia (Law No. 1351, 2020), Venezuela (as a medical compound), and Honduras (Decree 104-2020). The precursor Sodium chlorite is approved as an orphan drug for ALS by the European Medical Agency (EMA-EU/3/13/1139). In Germany, the BfArM classifies MMS as an unapproved medicinal product when marketed as a cure, but it is permitted as a water purifier (BASG, 2020,). Penalties (FDA, 2020) targeted improper marketing, not the substance itself. A former '''[https://www.fda.gov/news-events/press-announcements/fda-warns-consumers-about-dangerous-and-potentially-life-threating-side-effects-miracle-mineral warning has been remooved].'''

== 3. Liability Issues for MMS Damages ==
'''Claim''': Professional liability insurance does not cover MMS-related damages. '''Rebuttal''': The assertion that professional liability insurance excludes coverage for damages related to the use of MMS (Miracle Mineral Solution) lacks empirical support. Chlorine dioxide, the active agent in MMS, has been utilized by an estimated 13 million individuals globally, notably under the auspices of COMUSAV, an association comprising over 5,000 medical doctors. Within this extensive user base, there have been no documented cases of liability claims arising from the therapeutic application of chlorine dioxide. Furthermore, adverse effects associated with its use have been reported at a low incidence rate of approximately 6.78%, predominantly characterized by minor and transient symptoms. Consequently, the potential for professional liability claims linked to MMS appears to be minimal. Thus, claims that liability insurance does not cover MMS-related complications are largely speculative and not substantiated by current real-world data.

== 4. Harmful Contaminants in MMS ==
'''Claim''': MMS contains 30% chlorine and chlorate. '''Rebuttal''': Chemical analysis shows less than 7.7% Cl₂/ClO₃⁻ in MMS (Noszticzius et al., 2013, doi:10.1371/journal.pone.0079157). CDS is electrolytically 99.9% pure. The “30%” claim is chemically implausible. As a chemist, the author should be fully aware of these chemical facts. Such a significant discrepancy strongly suggests intentional misinformation rather than a mere misunderstanding of the chemistry involved. Misrepresenting chemical composition in this way undermines scientific accuracy and misleads the public.

== 5. Toxicity and Lack of Efficacy ==
'''Claim''': ClO₂ is toxic, and studies show no therapeutic effect. '''Rebuttal''': Studies demonstrate efficacy and safety:

* Aparicio-Alonso et al. (2024, doi:10.56294/saludcyt20241162): 99.3% efficacy in COVID-19 (1,136 patients, 4.84-day recovery).
* Noszticzius et al. (2013, doi:10.1371/journal.pone.0079157): Efficacy against MRSA.
* Fernández et al. (2024, doi:10.56294/saludcyt2024699): Positive effects in cancer.
* Insuasty et al. (2022, doi:10.3390/jcm11051404): Antibacterial efficacy.
* Ma et al. (2017, doi:10.1016/j.jes.2017.03.017): Safety at low doses.
* Morales et al. (2023, doi:10.3390/microorganisms11092231): Antiviral efficacy. Toxicity occurs only at >295 mg/kg (EPA, 2020,), unattainable at 30 mg/day.

== 6. ClO₂ Safe Only in Extreme Dilution ==
'''Claim''': ClO₂ is safe only in “bathtub-level” dilution. '''Rebuttal''': EPA/WHO confirm safety at 0.8 mg/L (EPA, 2020,). CDS doses (1–3 mg/L, 30 mg/day) are safe (Lubbers et al., 1982, doi:10.1289/ehp.824663). The NOAEL is 295 mg/kg (20,650 mg/day for a 70-kg person), unattainable via oral intake.

== 7. Confusion of Disinfection and Antibacterial Action ==
'''Claim''': CDS acts only as a disinfectant, not an antibiotic. '''Rebuttal''': Noszticzius et al. (2013, doi:10.1371/journal.pone.0079157) and Insuasty et al. (2022, doi:10.3390/jcm11051404) demonstrate antibacterial efficacy against resistant bacteria, refuting the claim.

== 8. ClO₂ as a Lung Toxin ==
'''Claim''': Gaseous ClO₂ causes pulmonary edema. '''Rebuttal''': CDS is administered orally, rectally, dermatologically, or i.v., not as a gas (Aparicio-Alonso et al., 2024, doi:10.56294/saludcyt20241162). CO₂ is toxic when inhaled but safe in mineral water, a distinction any toxicologist recognizes.

== 9. MMS-2 Releases Chlorine ==
'''Claim''': MMS-2 releases toxic chlorine in the stomach. '''Rebuttal''': MMS-2 (calcium hypochlorite) releases HOCl, not Cl₂ (Young, 2016, doi:10.15406/ijvv.2016.02.00052). As a chemist, the author should know this, suggesting error or intent. Kalcker rejects MMS-2 as unrelated to CDS.

== 10. Jim Humble and Scientology ==
'''Claim''': Humble was a Scientologist and founded an MMS church. '''Rebuttal''': This ad hominem claim is unscientific and suggests deliberate manipulation by the author. CDS efficacy (Aparicio-Alonso et al., 2024) is independent of Humble’s background.

== 11. No Proven Therapeutic Effect ==
'''Claim''': No studies confirm CDS efficacy. '''Rebuttal''': Studies listed at <nowiki>https://dioxipedia.com/index.php?title=CDS_Research_Studies</nowiki> confirm efficacy:

* Aparicio-Alonso et al. (2024, doi:10.56294/saludcyt20241162): COVID-19.
* Noszticzius et al. (2013, doi:10.1371/journal.pone.0079157): MRSA.
* Fernández et al. (2024, doi:10.56294/saludcyt2024699): Cancer.
* Insuasty et al. (2022, doi:10.3390/jcm11051404): Antibacterial.
* Ma et al. (2017, doi:10.1016/j.jes.2017.03.017): Safety.
* Morales et al. (2023, doi:10.3390/microorganisms11092231): Antiviral. Case reports document success in infections and cancer.

== 12. Healing Reports Are Placebo ==
'''Claim''': CDS healings are placebo effects. '''Rebuttal''': Animal studies (e.g., Dioxipedia case reports) show effects not attributable to placebo, as animals are not susceptible to placebo responses. Aparicio-Alonso et al. (2024, doi:10.56294/saludcyt20241162) report statistically significant recovery rates (99.3%).

== 13. Herxheimer Reaction ==
'''Claim''': Symptoms like diarrhea are poisonings. '''Rebuttal''': CDS contains no chlorite, only pure ClO₂ (Noszticzius et al., 2013, doi:10.1371/journal.pone.0079157), so chlorite-induced diarrhea is impossible. Side effects (6.78%) are redox-based, resembling Herxheimer reactions (Aparicio-Alonso et al., 2024). The claim is scientifically false.

== 14. Non-Patentability of ClO₂ ==
'''Claim''': ClO₂ is not patentable, so there is no pharmaceutical interest. '''Rebuttal''': Kalcker holds patents (e.g., CN 103720709, Allinger & Ogata; US 4317814, Swenholt). Tetrachlordecaoxide is patented (Hinz et al., 1986, PubMed). WHO bias due to Gates/pharma funding (Zumach, 2020) may explain CDS rejection.

== 15. Sodium Chlorite and ALS ==
'''Claim''': Sodium chlorite (ALS drug) is not comparable to MMS. '''Rebuttal''': Sodium chlorite is an EMA-approved orphan drug for ALS (EMA/OD/000/17). Under metabolic acidosis (e.g., ALS), NaClO₂ reacts to ClO₂, with immunomodulatory effects (Noszticzius et al., 2013, doi:10.1371/journal.pone.0079157).

== 16. CDS in Autism ==
'''Claim''': CDS enemas harm autistic children. '''Rebuttal''': Hundreds of autism remission cases are documented (Dioxitube videos). Fernández et al. (2024, doi:10.56294/saludcyt2024699) demonstrate safety. No studies confirm harm.

== 17. Opportunity Costs of CDS ==
'''Claim''': CDS delays effective treatments. '''Rebuttal''': CDS is used palliatively when standard treatments fail, with clinical success (Aparicio-Alonso et al., 2024, doi:10.56294/saludcyt20241162). Rapid recovery (4.84 days) does not delay treatment windows.

== 18. Advisory Services in the CDS Community ==
'''Claim''': CDS advisors provide dangerous advice. '''Rebuttal''': Studies (Aparicio-Alonso et al., 2024) confirm safety. Medical errors cause 250,000 deaths/year in the US (Makary & Daniel, 2016, doi:10.1136/bmj.i2139) vs. 40,000 from car accidents (NHTSA, 2020).

== 19. Redox Potential and Cell Voltage ==
'''Claim''': “Cell voltage” is scientifically invalid. '''Rebuttal''': ClO₂ has a redox potential of 940 mV; pathogens cannot survive >90 mV due to their size and single-cell structure (Noszticzius et al., 2013, doi:10.1371/journal.pone.0079157). The author demonstrates ignorance of redox potentials.

== 20. “Pure” ClO₂ in CDS ==
'''Claim''': CDS contains chlorine and contaminants. '''Rebuttal''': CDS is electrolytically 99.9% pure (Noszticzius et al., 2013). The body contains 100–140 g chlorine (0.15–0.2%, Guyton & Hall, 2016); quantity, not presence, is critical.

== 21. DMSO as an Effect Enhancer ==
'''Claim''': DMSO is ineffective and reacts with ClO₂. '''Rebuttal''': DMSO reacts to MSM, a safe supplement (Mazzio et al., 2023, doi:10.1016/j.jff.2023.105687). Fernández et al. (2024) confirm enhanced penetration. The claim lacks evidence, contradicted by thousands of clinical videos.

== 22. Malaria Healing Reports ==
'''Claim''': CDS malaria cures are unproven. '''Rebuttal''': A Red Cross field test in Iganga, Uganda (12.12.2012, <nowiki>https://dioxitube.com/w/iq5bGWNCmkCkF4uQyZcBrG</nowiki>), documented by three camera teams, showed 100% success in 154 cases. Aparicio-Alonso et al. (2024) support antiviral efficacy.

== 23. ClO₂ in Wound Treatment ==
'''Claim''': ClO₂ is suitable for wound treatment, but MMS contains byproducts. '''Rebuttal''': CDS is pure (Noszticzius et al., 2013). Nosocomial necrosis remission is possible (<nowiki>https://dioxipedia.com/index.php?title=Post_surgery_nosocomial_necrosis</nowiki>). The author’s failure to distinguish CDS from MMS indicates scientific ignorance.

== 24. Dosing Chaos ==
'''Claim''': CDS dosing is chaotic. '''Rebuttal''': Standard Protocol C (10 ml CDS at 3,000 ppm in 1,000 ml water, 30 mg/day) and other protocols are precise (Kalcker, 2023,).

== 25. Free Radicals from ClO₂ ==
'''Claim''': Free radicals from ClO₂ are harmful. '''Rebuttal''': CDS has a redox potential of 940 mV, below O₂ (1,280 mV), acting as an antioxidant against OH radicals (2,800 mV) by reducing superoxide to H₂O/O₂ (El Fakir et al., 2023, doi:10.1016/j.freeradbiomed.2023.05.034).

== WHO and Pharmaceutical Bias ==
WHO funding from Gates (339 million USD/year) and pharmaceutical companies (Zumach, 2020) may favor patentable drugs, explaining CDS rejection. Studies like Aparicio-Alonso et al. (2024) refute the “quackery” label.